Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1908 1
1971 1
1988 1
1989 2
1991 1
1992 3
1993 1
1994 3
1995 2
1997 3
1998 3
1999 1
2000 1
2001 8
2002 4
2003 4
2004 9
2005 13
2006 13
2007 14
2008 15
2009 16
2010 18
2011 18
2012 16
2013 16
2014 19
2015 19
2016 26
2017 21
2018 22
2019 19
2020 8
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 19369404

288 results
Results by year
Filters applied: . Clear all
Page 1
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group. Appel GB, et al. J Am Soc Nephrol. 2009 May;20(5):1103-12. doi: 10.1681/ASN.2008101028. Epub 2009 Apr 15. J Am Soc Nephrol. 2009. PMID: 19369404 Free PMC article. Clinical Trial.
Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R. Mejía-Vilet JM, et al. J Rheumatol. 2015 Nov;42(11):2082-91. doi: 10.3899/jrheum.150395. Epub 2015 Sep 15. J Rheumatol. 2015. PMID: 26373566
Mycophenolate mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus nephritis in a Japanese population: a retrospective study.
Onishi A, Sugiyama D, Tsuji G, Nakazawa T, Kogata Y, Tsuda K, Naka I, Nishimura K, Misaki K, Kurimoto C, Hayashi H, Kageyama G, Saegusa J, Sugimoto T, Kawano S, Kumagai S, Morinobu A. Onishi A, et al. Mod Rheumatol. 2013 Jan;23(1):89-96. doi: 10.1007/s10165-012-0634-9. Epub 2012 Mar 25. Mod Rheumatol. 2013. PMID: 22447557
Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, Teo SM, Wong HS, Tan SY, Shaariah W, Tan CC, Morad Z. Ong LM, et al. Nephrology (Carlton). 2005 Oct;10(5):504-10. doi: 10.1111/j.1440-1797.2005.00444.x. Nephrology (Carlton). 2005. PMID: 16221103 Clinical Trial.
Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
El-Shafey EM, Abdou SH, Shareef MM. El-Shafey EM, et al. Clin Exp Nephrol. 2010 Jun;14(3):214-21. doi: 10.1007/s10157-010-0270-7. Epub 2010 Feb 19. Clin Exp Nephrol. 2010. PMID: 20169461 Clinical Trial.
Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, Shen P, Chen N. Li X, et al. Nephrol Dial Transplant. 2012 Apr;27(4):1467-72. doi: 10.1093/ndt/gfr484. Epub 2011 Sep 13. Nephrol Dial Transplant. 2012. PMID: 21917733 Clinical Trial.
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis with poor kidney function: a subgroup analysis of the Aspreva Lupus Management Study.
Walsh M, Solomons N, Lisk L, Jayne DR. Walsh M, et al. Am J Kidney Dis. 2013 May;61(5):710-5. doi: 10.1053/j.ajkd.2012.11.042. Epub 2013 Feb 1. Am J Kidney Dis. 2013. PMID: 23375819 Clinical Trial.
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB. Ginzler EM, et al. N Engl J Med. 2005 Nov 24;353(21):2219-28. doi: 10.1056/NEJMoa043731. N Engl J Med. 2005. PMID: 16306519 Free article. Clinical Trial.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis.
Radhakrishnan J, Moutzouris DA, Ginzler EM, Solomons N, Siempos II, Appel GB. Radhakrishnan J, et al. Kidney Int. 2010 Jan;77(2):152-60. doi: 10.1038/ki.2009.412. Epub 2009 Nov 4. Kidney Int. 2010. PMID: 19890271 Free article. Clinical Trial.
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.
Isenberg D, Appel GB, Contreras G, Dooley MA, Ginzler EM, Jayne D, Sánchez-Guerrero J, Wofsy D, Yu X, Solomons N. Isenberg D, et al. Rheumatology (Oxford). 2010 Jan;49(1):128-40. doi: 10.1093/rheumatology/kep346. Epub 2009 Nov 20. Rheumatology (Oxford). 2010. PMID: 19933596 Free PMC article. Clinical Trial.
288 results
Jump to page
Feedback